Early discovery data shows ability of castle biosciences' pipeline program to distinguish between responders and non-responders to an atopic dermatitis therapy

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced new data related to its inflammatory skin disease pipeline program.

CSTL Ratings Summary

CSTL Quant Ranking